David Andrew Mccall, MD
Orthopaedic Surgery · Mountain View
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Probation Completed
- 2 Medical Board actions on record
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mccall’s office at (650) 934-7111 to ask if they take your plan before you enroll.
California Medical Board record
Licence A105536 · Current
Licensed to practise in California · since 2008 · expires 2028-04-30 · Howard University College of Medicine. Board flags: Probation Completed, Admin Action By Other State/Fed Gov'T.
Public record actions
| 2022-12-07 | Board disciplineDiscipline | Probation completed. · 8002015012621 |
| 2020-02-13 | Action in another state or by a federal agencyDiscipline | Voluntary surrender of hawaii medical license; and assessed a fine. · Hawaii medical board |
Drugs they prescribed that Part D paid
$19,214
Pharmacies billed $19,214 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 270) in 2024. At or below the middle of the specialty; the typical orthopaedic surgery clinician is at 18%.
249 generic and fewer than 11 brand-name prescriptions · $19,214 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amlodipine Besylate | 23 | $337 | $15 |
| Mirtazapine | 21 | $276 | $13 |
| Atorvastatin | 18 | $176 | $10 |
| Omeprazole | 11 | $175 | $16 |
| Losartan | 13 | $150 | $12 |
See all 6 drugs
| Amlodipine Besylate | 23 | $337 | $15 |
| Mirtazapine | 21 | $276 | $13 |
| Atorvastatin | 18 | $176 | $10 |
| Omeprazole | 11 | $175 | $16 |
| Losartan | 13 | $150 | $12 |
| Alprazolam | 11 | $43 | $4 |
Year by year
| 2024 | 270 | 94 | 0% (0) | None | $19,214 |
| 2023 | 1,018 | 202 | 0% (0) | 15% | $134,246 |
| 2015 | 17 | 11 | None | None | $304 |
| 2014 | 73 | 39 | 53% (39) | None | $2,144 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Ozempic | 16 | $21,651 | $1,353 |
| Jardiance | 11 | $13,722 | $1,247 |
| Rosuvastatin | 27 | $1,506 | $56 |
| Amlodipine Besylate | 62 | $1,303 | $21 |
| Omeprazole | 48 | $1,114 | $23 |
| Losartan | 52 | $998 | $19 |
| Atorvastatin | 46 | $903 | $20 |
| Gabapentin | 33 | $873 | $26 |
| Metformin | 44 | $806 | $18 |
| Levothyroxine | 37 | $802 | $22 |
| Mirtazapine | 21 | $801 | $38 |
| Metoprolol | 21 | $713 | $34 |
| Albuterol Sulfate Hfa | 11 | $641 | $58 |
| Lisinopril | 22 | $586 | $27 |
| Alendronate | 20 | $528 | $26 |
| Tamsulosin | 17 | $513 | $30 |
| Simvastatin | 15 | $381 | $25 |
| Diclofenac | 11 | $303 | $28 |
| Famotidine | 11 | $168 | $15 |
| Furosemide | 16 | $167 | $10 |
| Naproxen | 13 | $95 | $7 |
| Hydrochlorothiazide | 13 | $32 | $2 |
2014: 2 drugs
| Hydrocodone-Acetaminophen | 33 | $450 | $14 |
| Diclofenac | 13 | $267 | $21 |
Money from drug and device companies
$386 in 2023
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $150 | 10 payments
|
| Lilly USA | Mounjaro | $138 | 4 payments
|
| Pfizer | Paxlovid | $41 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $24 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $20 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $14 | 1 payment
|
See all 19 published payments
| Dexcom | Meals · 2023-06-03 | Dexcom G6 Transmitter | $20 |
| GlaxoSmithKline | Meals · 2023-06-01 | Trelegy Ellipta | $24 |
| Novo Nordisk | Meals · 2023-05-25 | Ozempic | $7 |
| Novo Nordisk | Meals · 2023-05-18 | Rybelsus | $16 |
| Lilly USA | Meals · 2023-05-16 | Mounjaro | $18 |
| Pfizer | Meals · 2023-05-16 | Paxlovid | $24 |
| Abbott Laboratories | Meals · 2023-05-14 | Freestyle Libre 3 | $14 |
| Novo Nordisk | Meals · 2023-05-12 | None | $17 |
| Novo Nordisk | Meals · 2023-05-10 | Rybelsus | $23 |
| Lilly USA | Meals · 2023-05-03 | Mounjaro | $83 |
| Pfizer | Meals · 2023-05-02 | Comirnaty | $17 |
| Novo Nordisk | Meals · 2023-04-27 | Rybelsus | $8 |
| Novo Nordisk | Meals · 2023-04-22 | Ozempic | $16 |
| Novo Nordisk | Meals · 2023-04-21 | Ozempic | $7 |
| Novo Nordisk | Meals · 2023-04-21 | Wegovy | $23 |
| Lilly USA | Meals · 2023-04-20 | Mounjaro | $15 |
| Novo Nordisk | Meals · 2023-04-12 | Ozempic | $24 |
| Novo Nordisk | Meals · 2023-04-04 | Ozempic | $9 |
| Lilly USA | Meals · 2023-03-15 | Jardiance | $23 |
Professional record
- NPI
- 1710174750
- Licence
- CA A105536California A105536: Current · expires 2028-04-30
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X); Student in a training program (390200000X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-10-03
- NPI last updated
- 2014-01-13
This is when the NPI record was last certified, not a medical board exam.